MATERIAL CHANGE REPORT
Item 1 — Name
and Address of Company
IM Cannabis Corp. (the “Company”)
Suite 2300 – 550 Burrard Street
Vancouver, BC, Canada, V6C 2B5
Item 2 — Date
of Material Change
The date of the material change was August 24,
Item 3 — News
A news release disclosing the material change was issued by the Company through the services of Canadian Newswire on August 24, 2022 and subsequently filed on the Company’s SEDAR profile at www.sedar.com.
Item 4 — Summary
of Material Change
The Company announced the closing of the first tranche of its non-brokered private placement offering, as described in the Company’s press release dated August 19, 2022, of 4,887,496 common shares of the
Company (the “Common Shares”) at a price of USD$0.50 per Common Share for aggregate proceeds of USD$2,443,748.
Item 5 — Full
Description of Material Change
5.1 – Full Description of
The Company announced that it closed the first tranche of its previously announced non-brokered private placement offering of up to
10,000,000 Common Shares for aggregate proceeds of up to US$5,000,000 (the “Offering”). The Company issued 4,887,496 Common Shares in the first tranche of the Offering at a price of USD$0.50 per Common Share for
aggregate proceeds of USD$2,443,748.
The Company intends to use the proceeds from the Offering for general working capital purposes.
All securities issued under the Offering are subject to a hold period of four months and one day from the closing date under
applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.
Insiders of the Company, lead by Oren Shuster, Chief Executive Officer and Director, and Shai Shemesh, Chief Financial Officer,
subscribed for 1,563,496 Common Shares for aggregate proceeds of US$781,748 (collectively, the “Insiders”). As a result of the participation by Insiders, the Offering is considered a “related party transaction” pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company relied on Sections 5.5(a) and 5.7(1)(a) of MI 61-101 for
exemptions from the requirements to obtain a formal valuation and minority shareholder approval, respectively, because the fair market value of the Insiders’
participation in the Offering was below 25% of the Company’s market capitalization for purposes of MI 61-101.
The Common Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws. Accordingly, the Common Shares may not be offered or sold within the United States, its territories or possessions, any state of the United States or the District of
Columbia (collectively, the “United States”) or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act) except in transactions exempt from the
registration requirements of the U.S. Securities Act and applicable securities laws of any state of the United States.
5.2 – Disclosure for
Item 6 — Reliance
on subsection 7.1(2) of National Instrument 51‑102
Item 7 — Omitted
Item 8 — Executive
Chief Legal and Operations Officer
Item 9 — Date
August 31, 2022
- 2 -